Pharmaceutical Software
Software, Data, and Services for Pharmaceutical Research
CSD data and software guide, inform and reduce risks at every stage for top pharmaceutical companies around the world, including Pfizer, Roche, AstraZeneca, Bristol Myers-Squibb and many more.
From target validation, to hit identification, lead optimization, solid form selection, formulation, and manufacturing, CSD data and software supports your drug development journey.
Included
Pharmaceutical Applications
Case Studies
Examples of CSD data and software in use to discover, develop, and formulate pharmaceuticals from the scientific literature.
Learn More
Dr Martin Stahl
CSO, Zenith Therapeutics
"The breadth and depth of CSD data is enormous today. It covers a lot of space of interest to medicinal chemistry."
Plus, you know that every structure you see has been derived from experiment. This leads to very high confidence in predictions based on CSD data, whether you predict a conformation or piece together a new structure from components.
Dr Gilles Ouvry
VP Chemistry, NRG Therapeutics
"Time and time again, going back to actual conformational data derived from small molecule Xray has helped me interpret structure activity relationships."
In this sense, CCDC is a truly a unique database and softwares such as ConQuest and Mercury have not only been linchpins of my design process but also a constant source of inspiration for years.
Dr John Liebeschuetz
CSO, Zenith Therapeutics
"Mogul is an excellent tool for identifying crystallographic problems with ligands in protein-ligand crystal structures."
Identifying truly unusual geometry in a ligand allows us to design that out, reducing strain and improving potency.
Dr Martin Stahl
CSO, Zenith Therapeutics
"The breadth and depth of CSD data is enormous today. It covers a lot of space of interest to medicinal chemistry."
Plus, you know that every structure you see has been derived from experiment. This leads to very high confidence in predictions based on CSD data, whether you predict a conformation or piece together a new structure from components.
Dr Gilles Ouvry
VP Chemistry, NRG Therapeutics
"Time and time again, going back to actual conformational data derived from small molecule Xray has helped me interpret structure activity relationships."
In this sense, CCDC is a truly a unique database and softwares such as ConQuest and Mercury have not only been linchpins of my design process but also a constant source of inspiration for years.
